Our clients’ research is paving the way for life saving treatments for cancer and rare inherited diseases. Common approaches to targeting a disease or genetic variation include gene addition, gene editing, RNA therapy, and cell therapy. 35 North’s team of specialists in cGMP construction and operations, enhanced commissioning, and operational readiness are fortunate to work alongside these innovators in the life sciences industry. With many possible therapy approaches to genetic disease or genetic variation, our firm specializes in helping life sciences organizations seamlessly bring their products to market.

If your life science organization is considering building new or renovating a highly regulated facility, connect with one of our experts, first.